Makale detayı · 2023 · article
The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıInfectious Diseases and Clinical Microbiology
- Katalog eşleşmesi (ISSN)Infectious Diseases and Clinical Microbiology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Objective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as ‘fully’ and ‘partially’ vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group’s need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection. Keywords: COVID-19 vaccine, intensive care unit, risk factor, SARS-CoV-2 infection, vaccine breakthrough infections, variant of concerns
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
3atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2024 Heterologous Versus Homologous COVID-19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous Versus Homologous COVID-19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex
- 2024 Heterologous vs. Homologous COVID-19 Boosters: Immune Response Outcomes in Renal Transplant RecipientsAtıf 1 · OpenAlex